Hachulla, E. & Launay, D. Diagnosis and classification of systemic sclerosis. Clin. Rev. Allergy Immunol. 40, 78–83 (2011).ArticleÂ
PubMedÂ
Google ScholarÂ
O’Reilly, S. Innate immunity in systemic sclerosis pathogenesis. Clin. Sci. 126, 329–337 (2014).ArticleÂ
Google ScholarÂ
Sargent, J. L. & Whitfield, M. L. Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling. Expert Rev. Clin. Immunol. 7, 463–473 (2011).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liu, C., Oikonomopoulos, A., Sayed, N. & Wu, J. C. Modeling human diseases with induced pluripotent stem cells: From 2D to 3D and beyond. Development 145, dev56166 (2018).ArticleÂ
Google ScholarÂ
Vijayaraj, P. et al. Modeling progressive fibrosis with pluripotent stem cells identifies an anti-fibrotic small molecule. Cell Rep. 29, 3488–3505 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xu, X. et al. Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods. PLoS One 15, e0242863 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Castro, S. V. & Jimenez, S. A. Biomarkers in systemic sclerosis. Biomark. Med. 4, 133–147 (2010).ArticleÂ
PubMedÂ
Google ScholarÂ
Desroy, N. et al. Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl] piperazin-1-yl]-8-methylimidazo [1, 2-a] pyridin-3-yl] methylamino]-4-(4-fluorophenyl) thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis. J. Med. Chem. 60, 3580–3590 (2017).ArticleÂ
PubMedÂ
Google ScholarÂ
Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 29, 15–21 (2013).ArticleÂ
PubMedÂ
Google ScholarÂ
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).ArticleÂ
PubMedÂ
Google ScholarÂ
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biolo. 15, 1–21 (2014).
Google ScholarÂ
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 28, 882–883 (2012).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 8, 118–127 (2007).ArticleÂ
PubMedÂ
Google ScholarÂ
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47–e47 (2015).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545–15550 (2005).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. Omics J. Integr. Biol. 16, 284–287 (2012).ArticleÂ
Google ScholarÂ
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lopez, R. et al. Deep generative modeling for single-cell transcriptomics. Nat. Methods 15, 1053–1058 (2018).ArticleÂ
PubMed CentralÂ
Google ScholarÂ
Traag, V. A., Waltman, L. & Van Eck, N. J. From Louvain to Leiden: Guaranteeing well-connected communities. Sci. Rep.. 9, 5233 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).ArticleÂ
PubMed CentralÂ
Google ScholarÂ
Bretschneider, T. et al. Ultrafast and predictive mass spectrometry-based autotaxin assays for label-free potency screening. SLAS Discov. 22, 425–432 (2017).ArticleÂ
PubMedÂ
Google ScholarÂ
Xu, S. et al. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. Eur. J. Pharmacol. 894, 173817 (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Liao, X. H. et al. VEGF-A stimulates STAT3 activity via nitrosylation of myocardin to regulate the expression of vascular smooth muscle cell differentiation markers. Sci. Rep. 7, 2660 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Peng, G. et al. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. J. Exp. Clin. Cancer Res. 40, 1–16 (2021).ArticleÂ
Google ScholarÂ
Zhang, H. et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J. Clin. Investig. 117, 730–738 (2007).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Filippou, P. S., Karagiannis, G. S. & Constantinidou, A. Midkine (MDK) growth factor: A key player in cancer progression and a promising therapeutic target. Oncogene 39, 2040–2054 (2020).ArticleÂ
PubMedÂ
Google ScholarÂ
Hu, K. et al. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget 7, 7816 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chong, H. C. et al. Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice. Mol. Therapy 22, 1593–1604 (2014).ArticleÂ
Google ScholarÂ
Wang, Q. et al. HIF-1α up-regulates NDRG1 expression through binding to NDRG1 promoter, leading to proliferation of lung cancer A549 cells. Mol. Biol. Rep. 40, 3723–3729 (2013).ArticleÂ
PubMedÂ
Google ScholarÂ
Tirado-Hurtado, I., Fajardo, W. & Pinto, J. A. DNA damage inducible transcript 4 gene: The switch of the metabolism as potential target in cancer. Front. Oncol. 8, 106 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, X., Hu, Z., Wang, Z., Cui, Y. & Cui, X. Angiopoietin-like protein 2 is an important facilitator of tumor proliferation, metastasis, angiogenesis and glycolysis in osteosarcoma. Am. J. Trans. Res. 11, 6341 (2019).
Google ScholarÂ
Horiguchi, H. et al. Angiopoietin-like protein 2 renders colorectal cancer cells resistant to chemotherapy by activating spleen tyrosine kinase–phosphoinositide 3-kinase-dependent anti-apoptotic signaling. Cancer Sci. 105, 1550–1559 (2014).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Limbad, C. et al. Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types. Iscience. 25, 103848 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lin, X. et al. lncRNA-ES3/miR-34c-5p/BMF axis is involved in regulating high-glucose-induced calcification/senescence of VSMCs. Aging. 11, 523 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Takaya, K., Asou, T. & Kishi, K. Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging. Aging 14, 8167 (2022).PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liu, X. L. et al. FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells. Int. J. Clin. Exp. Pathol. 7, 1534 (2014).PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wu, D. et al. Single-cell metabolic imaging reveals a SLC2A3-dependent glycolytic burst in motile endothelial cells. Nat. Metab. 3, 714–727 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Katoh, D. et al. Tenascin-C induces phenotypic changes in fibroblasts to myofibroblasts with high contractility through the integrin αvβ1/transforming growth factor β/SMAD signaling axis in human breast cancer. Am. J. Pathol. 190, 2123–2135 (2020).ArticleÂ
PubMedÂ
Google ScholarÂ
Zhuang, Y., Li, X., Zhan, P., Pi, G. & Wen, G. MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein. Oncol. Rep. 45, 1–1 (2021).ArticleÂ
Google ScholarÂ
Takano, M. et al. ANGPTL2 promotes inflammation via integrin α5β1 in chondrocytes. Cartilage 13, 885S-897S (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Walton, K. L., Johnson, K. E. & Harrison, C. A. Targeting TGF-β mediated SMAD signaling for the prevention of fibrosis. Front. Pharmacol. 8, 461 (2017).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Flynn, R. S. et al. Endogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn’s disease strictures. Inflamm. Bowel Dis. 17, 193–201 (2011).ArticleÂ
PubMedÂ
Google ScholarÂ
Zheng, Z. et al. CRLF1 is a key regulator in the ligamentum flavum hypertrophy. Front. Cell Dev. Biol. 8, 858 (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yang, Z. et al. UNC5B promotes vascular endothelial cell senescence via the ROS-mediated P53 pathway. Oxid. Med. Cell. Longev. https://doi.org/10.1155/2021/5546711 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xu, X. H. et al. Interleukin-6 released by oral lichen planus myofibroblasts promotes angiogenesis. Exp. Ther. Med. 21, 1–1 (2021).ArticleÂ
Google ScholarÂ
Lessey-Morillon, E. C. et al. The RhoA GEF, LARG, mediates ICAM-1-dependent mechanotransduction in endothelial cells to stimulate transendothelial migration. J. Immunol. 192, 3390 (2014).ArticleÂ
PubMedÂ
Google ScholarÂ
Mengie Ayele, T., Tilahun Muche, Z., Behaile Teklemariam, A., Bogale Kassie, A. & Chekol Abebe, E. Role of JAK2/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: A systemic review. J. Inflamm. Res. 15, 1349–1364 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Oh, S. et al. Effect of mechanical stretch on the DNCB-induced proinflammatory cytokine secretion in human keratinocytes. Sci. Rep.. 9, 5156 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Di, X. et al. Cellular mechanotransduction in health and diseases: From molecular mechanism to therapeutic targets. Signal Transduct Target. Therapy 8, 282 (2023).ArticleÂ
Google ScholarÂ
Du, H. et al. Tuning immunity through tissue mechanotransduction. Nat. Rev. Immunol. 23, 174–188 (2023).ArticleÂ
PubMedÂ
Google ScholarÂ
Dupont, S., Morsut, L., Aragona, M., et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474(7350):179–183. https://doi.org/10.1038/nature10137 Reddy, P., Deguchi, M., Cheng, Y., & Hsueh, A. J. (2013)Totaro, A., Panciera, T. & Piccolo, S. YAP/TAZ upstream signals and downstream responses. Nat Cell Biol 20, 888–899 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
van der Stoel, M. et al. DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis. J Cell Sci. 133(3), jcs239947 (2020).ArticleÂ
PubMedÂ
Google ScholarÂ
Xie, Z. et al. Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation. Nat. Commun. 13(1), 50 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chow, S. E., Hsu, C. C., Yang, C. T. & Meir, Y. J. YAP co-localizes with the mitotic spindle and midbody to safeguard mitotic division in lung-cancer cells. FEBS J. 290(24), 5704–5719 (2023).ArticleÂ
PubMedÂ
Google ScholarÂ
Nakamura, F. The role of mechanotransduction in contact inhibition of locomotion and proliferation. Int. J. Mol. Sci. 25(4), 2135 (2024).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liu, Y. P., Pan, L. L. & Kong, C. C. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1. Eur. Rev. Med. Pharmacol. Sci. 24(13), 7335–7344 (2020).PubMedÂ
Google ScholarÂ
Lee, Y. B. et al. Function of a complex of p-Y42 RhoA GTPase and pyruvate kinase M2 in EGF signaling pathway in glioma cells. J. Neurochem. https://doi.org/10.1111/jnc.16210 (2024).ArticleÂ
PubMedÂ
Google ScholarÂ
Mao, M. et al. HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer. Cell Death Dis. 13(4), 396 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yu, Z. et al. IL-17A promotes psoriasis-associated keratinocyte proliferation through ACT1-dependent activation of YAP-AREG Axis. J. Invest. Dermatol. 142(9), 2343–2352 (2022).ArticleÂ
PubMedÂ
Google ScholarÂ
Lin, K. C. et al. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation. Nat. Cell Biol. 9(8), 996–1002 (2018).ArticleÂ
Google ScholarÂ
Xiao, Y. & Dong, J. The hippo signaling pathway in cancer: A cell cycle perspective. Cancers 13(24), 6214 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Brindley, D. N. & Raouf, A. Autotaxin is an important component of the tumor microenvironment and a major modulator of therapy responses for breast cancer. In Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (eds Freywald, A. & Vizeacoumar, F.) 47–63 (Elsevier, 2021).ChapterÂ
Google ScholarÂ
Hernandez-Gonzalez, F. et al. Cellular senescence in lung fibrosis. Int. J. Mol. Sci. 22, 7012 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Maciejewska, M. et al. Hypoxia-inducible factor-1α (HIF-1α) as a biomarker for changes in microcirculation in individuals with systemic sclerosis. Dermatol. Therapy 13, 1549–1560 (2023).ArticleÂ
Google ScholarÂ
Mao, J. et al. Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis. Plos one 17, e0263369 (2022).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Castelino, F. V. et al. An autotaxin/lysophosphatidic acid/interleukin-6 amplification loop drives scleroderma fibrosis. Arthritis Rheumatol. 68, 2964–2974 (2016).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, Z., Yao, L., Yang, J., Wang, Z. & Du, G. PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia. Mol. Med. Rep. 18, 3547–3554 (2018).PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Cain, R. J. & Ridley, A. J. Phosphoinositide 3-kinases in cell migration. Biol. Cell. 101, 13–29 (2009).ArticleÂ
PubMedÂ
Google ScholarÂ